Teva Pharmaceutical Industries LimitedTEVANYSE
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, slight contraction.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$4.43B
↑ 257% above average
Average (9y)
$1.24B
Historical baseline
Range
High:$6.34B
Low:$-15.52B
CAGR
-3.9%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $4.43B | +184.4% |
| 2023 | $1.56B | +268.4% |
| 2022 | $-925.00M | -121.0% |
| 2021 | $4.41B | -4.4% |
| 2020 | $4.61B | +3.9% |
| 2019 | $4.44B | +2286.0% |
| 2018 | $186.00M | +101.2% |
| 2017 | $-15.52B | -641.4% |
| 2016 | $2.87B | -54.8% |
| 2015 | $6.34B | - |